Galapagos enters partnership with Gilead for autoimmune drug development
Go back to Galapagos enters partnership with Gilead for autoimmune drug development| Gilead Sciences (NASDAQ: GILD) | Delayed: 138.36 +0.22 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.14 | 52 Week High | $108.63 | |||
| Open | $136.81 | 52 Week Low | $71.39 | |||
| Day High | $138.43 | P/E | 76.44 | |||
| Day Low | $135.91 | EPS | $1.81 | |||
| Volume | 3,407,717 | |||||
| (NASDAQ: GLPG) | Delayed: 27.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.73 | 52 Week High | $73.37 | |||
| Open | $27.73 | 52 Week Low | $37.03 | |||
| Day High | $27.73 | P/E | N/A | |||
| Day Low | $27.73 | EPS | $0.00 | |||
| Volume | 135,138 | |||||
